Early epigenetic events regulate the adaptive immune response gene CIITA

Epigenetics

Volumn 6, Issue 4, 2011, Pages 516-525

  Mehta, Ninad T ^a   Truax, Agnieszka D ^a   Boyd, Nathaniel H ^a   Greer, Susanna F ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Class II transactivatoran; Epigenetics; Histone modifications; Histone remodeling enzymes; Major histocompatibility complex class II; Transcriptional regulation

Indexed keywords

CLASS II TRANSACTIVATOR PROTEIN; DNA; HISTONE METHYLTRANSFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; EZH2 PROTEIN, HUMAN; GAMMA INTERFERON; HISTONE; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENETIC REGULATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; ACETYLATION; CHEMISTRY; GENETIC EPIGENESIS; GENETICS; HELA CELL; METABOLISM; METHYLATION; PHYSIOLOGY;

ACETYLATION; ADAPTIVE IMMUNITY; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HELA CELLS; HISTONES; HUMANS; INTERFERON-GAMMA; METHYLATION; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 79954480753     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.4.14516     Document Type: Article

References (53)

1. Gelin C, Sloma I, Charron D, Mooney N. Regulation of MHC II and CD1 antigen presentation: from ubiquity to security. J Leukoc Biol 2009; 85:215-24.
2. Chang CH, Fontes JD, Peterlin M, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994; 180:1367-74.
3. Kaufman JF, Auffray C, Korman AJ, Shackelford DA, Strominger J. The class II molecules of the human and murine major histocompatibility complex. Cell 1984; 36:1-13.
4. Handunnetthi L, Ramagopalan SV, Ebers GC, Knight JC. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immun 2010; 11:99-112.
5. Adamski J, Ma Z, Nozell S, Benveniste EN. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. Mol Endocrinol 2004; 18:1963-74.
6. Murphy SP, Choi JC, Holtz R. Regulation of major histocompatibility complex class II gene expression in trophoblast cells. Reprod Biol Endocrinol 2004; 2:52.
7. Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005; 5:793-806.
8. Boss JM, Jensen PE. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr Opin Immunol 2003; 15:105-11.
9. Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, et al. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 1984; 81:4917-21.
10. Piskurich JF, Linhoff MW, Wang Y, Ting JP. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1 and transforming growth factor beta. Mol Cell Biol 1999; 19:431-40.
11. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 1997; 16:2851-60.
12. Landmann S, Muhlethaler-Mottet A, Bernasconi L, Suter T, Waldburger JM, Masternak K, et al. Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J Exp Med 2001; 194:379-91.
13. Lennon AM, Ottone C, Rigaud G, Deaven LL, Longmire J, Fellous M, et al. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 1997; 45:266-73.
14. Piskurich JF, Gilbert CA, Ashley BD, Zhao M, Chen H, Wu J, et al. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFNgamma. Mol Immunol 2006; 43:519-28.
15. Reith W, Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 2001; 19:331-73.
16. Piskurich JF, France JA, Tamer CM, Willmer CA, Kaetzel CS, Kaetzel DM. Interferon-gamma induces polymeric immunoglobulin receptor mRNA in human intestinal epithelial cells by a protein synthesis dependent mechanism. Mol Immunol 1993; 30:413-21.
17. Piskurich JF, Youngman KR, Phillips KM, Hempen PM, Blanchard MH, France JA, et al. Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-gamma. Mol Immunol 1997; 34:75-91.
18. Beresford G, Boss J. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat Immunol 2001; 2:652-7.
19. Pattenden SG, Klose R, Karaskov E, Bremner R. Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent. EMBO J 2002; 21:1978-86.
20. Agalioti T, Chen G, Thanos D. Deciphering the transcriptional histone acetylation code for a human gene. Cell 2002; 111:381-92.
21. Morris AC, Beresford GW, Mooney MR, Boss JM. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. Mol Cell Biol 2002; 22:4781-91.
22. Ni Z, Karaskov E, Yu T, Callaghan SM, Der S, Park DS, et al. Apical role for BRG1 in cytokine-induced promoter assembly. Proc Natl Acad Sci USA 2005; 102:14611-6.
23. Sisk TJ, Gourley T, Roys S, Chang CH. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300. J Immunol 2000; 165:2511-7.
24. Morris A, Spangler W, Boss J. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control. J Immunol 2000; 164:4143-9.
25. Truax AD, Koues OI, Mentel MK, Greer SF. The 19S ATPase S6a (S6'/TBP1) regulates the transcription initiation of class II transactivator. J Mol Biol 2010; 395:254-69.
26. Ting JP, Trowsdale J. Genetic control of MHC class II expression. Cell 2002; 109:21-33.
27. Guy K, Krajewski AS, Dewar AE. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma. Br J Cancer 1986; 53:161-73.
28. Santin AD, Hermonat PL, Ravaggi A, Chiriva-Internati M, Hiserodt JC, Pecorelli S, et al. Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/ costimulation molecules ICAM-1 in human cervical cancer. Gynecol Oncol 1998; 70:195-201.
29. Gorisch SM, Wachsmuth M, Toth KF, Lichter P, Rippe K. Histone acetylation increases chromatin accessibility. J Cell Sci 2005; 118:5825-34.
30. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem 2001; 70:81-120.
31. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293:1074-80.
32. Wright K, Ting J. Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol 2006; 27:405-12.
33. Koues O, Dudley R, Mehta N, Greer S. The 19S proteasome positively regulates histone methylation at cytokine inducible genes. Biochim Biophys Acta 2009.
34. Wu M, Wang PF, Lee JS, Martin-Brown S, Florens L, Washburn M, et al. Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS. Mol Cell Biol 2008; 28:7337-44.
35. Ng HH, Robert F, Young RA, Struhl K. Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol Cell 2003; 11:709-19.
36. Muhlethaler-Mottet A, Di Berardino W, Otten LA, Mach B. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity 1998; 8:157-66.
37. Bannister AJ, Kouzarides T. Histone methylation: recognizing the methyl mark. Methods Enzymol 2004; 376:269-88.
38. Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev 2004; 18:1263-71.
39. Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008; 647:21-9.
40. Martinez-Garcia E, Licht JD. Deregulation of H3K27 methylation in cancer. Nat Genet 2010; 42:100-1.
41. Holling TM, Bergevoet MWT, Wilson L, Van Eggermond MCJA, Schooten E, Steenbergen RDM, et al. A role for EZH2 in silencing of IFNgamma inducible MHC2TA transcription in uveal melanoma. Journal of Immunology 2007; 179:5317-25.
42. Gerloni M, Zanetti M. CD4 T cells in tumor immunity. Springer Semin Immunopathol 2005; 27:37-48.
43. Morimoto Y, Toyota M, Satoh A, Murai M, Mita H, Suzuki H, et al. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells. Br J Cancer 2004; 90:844-52.
44. Holling TM, van Eggermond MC, Jager MJ, van den Elsen PJ. Epigenetic silencing of MHC2TA transcription in cancer. Biochem Pharmacol 2006; 72:1570-6.
45. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28.
46. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21:163-7.
47. Schulz WA, Hatina J. Epigenetics of prostate cancer: beyond DNA methylation. J Cell Mol Med 2006; 10:100-25.
48. Cooper CS, Foster CS. Concepts of epigenetics in prostate cancer development. Br J Cancer 2009; 100:240-5.
49. Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, et al. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol 2010; 12:1108-14.
50. Koues OI, Mehta NT, Truax AD, Dudley RK, Brooks JK, Greer SF. Roles for common MLL/COMPASS subunits and the 19S proteasome in regulating CIITA pIV and MHC class II gene expression and promoter methylation. Epigenetics Chromatin 2010; 3:5.
51. Bhat KP, Truax AD, Greer SF. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression. J Biol Chem 2010; 285:25893-903.
52. Bhat K, Turner J, Myers S, Cape A, Ting J, Greer S. The 19S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription. Mol Immunol 2008; 45:2214-24.
53. Koues O, Dudley R, Truax A, Gerhardt D, Bhat K, McNeal S, et al. Regulation of Acetylation at the MHC-II Proximal Promoter by the 19S Proteasomal ATPase Sug1. Mol Cell Biol 2008; 28:5837-50.